Nestle India Limited Max Pain Analysis
What is Max Pain?
Max Pain theory states the underlying gravitates toward the strike where option writers face minimum collective loss at expiry. For NESTLEIND, that strike is ₹1,250. Spot at ₹1,296 is 3.68% above max pain — possible downward gravitational pull into expiry.
Max Pain Level
The max pain for NESTLEIND on 2026-04-21 is ₹1250, the strike where option sellers face minimal total loss. This level often acts as a magnet in the final days, as writer positioning resists price movement away from it.
Spot vs Max Pain Gap
The spot price at ₹1296 is 3.68% above the ₹1250 max pain, indicating a notable upward gap. This mispricing may draw downward pressure, as the tendency favors price drift toward the point of least option writer pain.
Shift Signal
The max pain remains unchanged from yesterday, suggesting stable writer concentrations at ₹1250. Persistent alignment implies entrenched short positions around this strike, reinforcing its gravitational influence.
Expiry Bias
With 7 days to expiry, a slight bearish drift is expected toward ₹1250, supported by the current pain distribution. However, the pull strengthens meaningfully only within the final five days, limiting conviction this far out.
Trader Note
Premium decay strategies are suggested only once daysToExpiry ≤ 5, when the ₹1250 max pain exerts stronger influence.
Data as of 2026-04-21